Whole slide imaging technology, which digitizes entire glass pathology slides for remote viewing, analysis, and archiving, has matured substantially from its earlier adoption phase, with more established vendors, more robust FDA-cleared diagnostic use cases, and clearer integration pathways with laboratory information systems than were available even a few years ago.
Why Facilities Are Investing
- Remote and subspecialty consultation becomes dramatically easier with digitized slides, allowing rapid second opinion or subspecialty review without physically shipping glass slides
- Workflow efficiency improves for pathologists managing high case volumes, with digital workflow tools supporting more efficient case triage and review than physical slide handling
- AI-assisted analysis tools increasingly integrate with whole slide imaging platforms, offering diagnostic support capability that isn't available with traditional microscopy
Key Procurement Evaluation Criteria
- Scanning throughput and image quality appropriate for the facility's actual case volume and subspecialty mix
- Laboratory information system integration depth, since a poorly integrated system creates workflow friction that can undermine adoption regardless of scanning hardware quality
- Storage infrastructure requirements, since whole slide images require substantial data storage capacity that facilities need to plan for as both capital and ongoing cost
Building the Business Case
Facilities evaluating this investment should weigh the workflow efficiency and subspecialty access benefits against the substantial capital and IT infrastructure investment required, recognizing that the strongest business cases tend to come from facilities with genuine subspecialty consultation needs or significant pathologist recruitment and retention challenges that remote work capability can help address.
Facilities building digital pathology capability can review Healix Medical Supply's lab supplies catalog.
